GENE ONLINE|News &
Opinion
Blog

Sangamo Therapeutics
Trials & Approvals Hemophilia A
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Ranking & Reports Gene Therapy
10 Top Gene Therapy Companies in 2021
2021-03-26
M&A Neuroscience
Novartis Looks to Diversify Neuroscience Pipeline with $770 Million Worth Acquisition
2020-12-22
Deals Gene Editing
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
In-Depth Cystic Fibrosis
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
R&D
Biogen-Sangamo Collaboration Comforts Millions Affected by Neurodegenerative Disorders
2020-02-29
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top